173 related articles for article (PubMed ID: 18651966)
1. P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases.
Pauser U; Schmedt Auf der Günne N; Klöppel G; Merz H; Feller AC
BMC Cancer; 2008 Jul; 8():204. PubMed ID: 18651966
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
Ihle MA; Huss S; Jeske W; Hartmann W; Merkelbach-Bruse S; Schildhaus HU; Büttner R; Sihto H; Sundby Hall K; Eriksson M; Reichardt P; Joensuu H; Wardelmann E
PLoS One; 2018; 13(2):e0193048. PubMed ID: 29451912
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
Sabah M; Cummins R; Leader M; Kay E
Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
[TBL] [Abstract][Full Text] [Related]
4. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome.
Feakins RM
Histopathology; 2005 Mar; 46(3):270-9. PubMed ID: 15720412
[TBL] [Abstract][Full Text] [Related]
5. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.
Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y
Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival.
Haller F; Cortis J; Helfrich J; Cameron S; Schüler P; Schwager S; Gunawan B; Füzesi L; Agaimy A
Mod Pathol; 2011 Feb; 24(2):248-55. PubMed ID: 20834236
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
8. SKP2 high expression, KIT exon 11 deletions, and gastrointestinal bleeding as predictors of poor prognosis in primary gastrointestinal stromal tumors.
Lv A; Li Z; Tian X; Guan X; Zhao M; Dong B; Hao C
PLoS One; 2013; 8(5):e62951. PubMed ID: 23690967
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy and c-Kit mutation in gastrointestinal stromal tumors.
Lee JH; Zhang X; Jung WY; Chae YS; Park JJ; Kim I
World J Gastroenterol; 2004 Dec; 10(23):3475-9. PubMed ID: 15526368
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.
Yoo C; Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S362-9. PubMed ID: 25791792
[TBL] [Abstract][Full Text] [Related]
11. Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors.
Nanding A; Tang L; Cai L; Chen H; Geng J; Liu X; Ning X; Li X; Zhang Q
Gastric Cancer; 2014 Jan; 17(1):87-96. PubMed ID: 23504291
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors - quantitative detection of the Ki-67, TPX2, TOP2A, and hTERT telomerase subunit mRNA levels to determine proliferation activity and a potential for aggressive biological behavior.
Kalfusova A; Hilska I; Krskova L; Kalinova M; Linke Z; Kodet R
Neoplasma; 2016; 63(3):484-92. PubMed ID: 26952515
[TBL] [Abstract][Full Text] [Related]
13. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
[TBL] [Abstract][Full Text] [Related]
14. KIT-negative gastrointestinal stromal tumors with a long term follow-up: a new subgroup does exist.
Kontogianni-Katsarou K; Lariou C; Tsompanaki E; Vourlakou C; Kairi-Vassilatou E; Mastoris C; Pantazi G; Kondi-Pafiti A
World J Gastroenterol; 2007 Feb; 13(7):1098-102. PubMed ID: 17373746
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors: clinical significance of p53 expression, MDM2 amplification, and KIT mutation status.
Wallander ML; Layfield LJ; Tripp SR; Schmidt RL
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):308-12. PubMed ID: 23060298
[TBL] [Abstract][Full Text] [Related]
16. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
17. Canine gastrointestinal stromal tumors: immunohistochemical expression of CD34 and examination of prognostic indicators including proliferation markers Ki67 and AgNOR.
Gillespie V; Baer K; Farrelly J; Craft D; Luong R
Vet Pathol; 2011 Jan; 48(1):283-91. PubMed ID: 20826846
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
Ryu MH; Kang YK; Jang SJ; Kim TW; Lee H; Kim JS; Park YH; Lee SS; Ryoo BY; Chang HM; Lee JL; Yook JH; Kim BS; Lee JS
Histopathology; 2007 Sep; 51(3):379-89. PubMed ID: 17727479
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors (GIST): a single center experience.
Kostka R; Gürlich R; Koldová L
Acta Chir Belg; 2012 Jan; 112(1):33-9. PubMed ID: 22442907
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.
Koay MH; Goh YW; Iacopetta B; Grieu F; Segal A; Sterrett GF; Platten M; Spagnolo DV
Pathology; 2005 Feb; 37(1):22-31. PubMed ID: 15875730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
